Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)

[This corrects the article DOI: 10.3389/fmed.2023.1122529.].

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2024-05, Vol.11, p.1375607-1375607
Main Authors: Patterson, Bruce K, Yogendra, Ram, Guevara-Coto, Jose, Mora-Rodriguez, Rodrigo A, Osgood, Eric, Bream, John, Parikh, Purvi, Kreimer, Mark, Jeffers, Devon, Rutland, Cedric, Kaplan, Gary, Zgoda, Michael
Format: Article
Language:English
Subjects:
CCR5 antagonist
fractalkine (CX3CR1)
long COVID
maraviroc
Medicine
PASC
statins
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[This corrects the article DOI: 10.3389/fmed.2023.1122529.].
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2024.1375607